| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1047287353 |
| P356 | DOI | 10.1186/1741-7015-3-17 |
| P932 | PMC publication ID | 1310534 |
| P698 | PubMed publication ID | 16316472 |
| P5875 | ResearchGate publication ID | 7453498 |
| P2093 | author name string | Antonio González-Pérez | |
| Luis A García Rodríguez | |||
| P2860 | cites work | Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis | Q24555478 |
| Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects | Q28167963 | ||
| Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population | Q28168963 | ||
| Cyclooxygenase inhibitors and the antiplatelet effects of aspirin | Q28191912 | ||
| Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs | Q28645859 | ||
| Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention | Q29620087 | ||
| Coxibs and cardiovascular disease | Q34356732 | ||
| Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study | Q45260921 | ||
| Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study | Q46481473 | ||
| Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women | Q73940124 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| myocardial infarction | Q12152 | ||
| P304 | page(s) | 17 | |
| P577 | publication date | 2005-11-29 | |
| P1433 | published in | BMC Medicine | Q4835947 |
| P1476 | title | Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population | |
| P478 | volume | 3 |
| Q95359587 | Q95359587 |
| Q35758411 | An evidence-based update on nonsteroidal anti-inflammatory drugs |
| Q34245387 | Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities |
| Q38429068 | Cardiovascular disease and non-steroidal anti-inflammatory drug prescribing in the midst of evolving guidelines |
| Q38201752 | Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studies. |
| Q34582722 | Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison |
| Q28298198 | Cardiovascular risk, hypertension, and NSAIDs |
| Q37049698 | Cardiovascular risk, hypertension, and NSAIDs. |
| Q38164425 | Cardiovascular risks associated with low-dose ibuprofen and diclofenac as used OTC. |
| Q36520638 | Cardiovascular risks of cyclooxygenase inhibition |
| Q30490432 | Characterization of the Adverse Effects Induced by Acetaminophen and Non-steroidal Anti-Inflammatory Drugs based on the Analysis of the Japanese Adverse Drug Event Report Database |
| Q46628463 | Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects |
| Q37947341 | Comparative risks of non-prescription analgesics: a structured topic review and research priorities. |
| Q33723762 | Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases |
| Q28273156 | Drugs for postoperative analgesia: routine and new aspects. Part 1: non-opioids |
| Q37842502 | Emerging drugs for treating skeletal muscle injury and promoting muscle repair |
| Q37085249 | Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists |
| Q64895914 | Kounis syndrome triggered by diclofenac sodium injection which leads to myocardial infarction and cardiac arrest. |
| Q38101544 | Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies |
| Q38693695 | Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Acute Myocardial Infarction in the General German Population: A Nested Case-Control Study |
| Q35827683 | Non-selective nonsteroidal anti-inflammatory drugs and cardiovascular events: is aldosterone the silent partner in crime? |
| Q35164718 | PharmGKB summary: ibuprofen pathways. |
| Q34281737 | Physiology. COX-2 inhibitors and cardiovascular risk |
| Q33871754 | Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis |
| Q99238880 | Prevalence of Gastrointestinal and Cardiovascular Risk in Patients with Degenerative Lumbar Spinal Disease |
| Q28195728 | Prevention and treatment of NSAID-induced gastroduodenal injury |
| Q34556831 | Relative cardiovascular and gastrointestinal safety of non-selective non-steroidal anti-inflammatory drugs versus cyclo-oxygenase-2 inhibitors: implications for clinical practice |
| Q56966953 | Riesgo cardiovascular en la artritis reumatoide. ¿Hasta dónde? |
| Q34148370 | Risk of new acute myocardial infarction hospitalization associated with use of oral and parenteral non-steroidal anti-inflammation drugs (NSAIDs): a case-crossover study of Taiwan's National Health Insurance claims database and review of current evi |
| Q64245288 | Safety of Topical Non-steroidal Anti-Inflammatory Drugs in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis |
| Q37534725 | The search for new COX-2 inhibitors: a review of 2002 - 2008 patents |
| Q33906348 | Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community |
| Q94601375 | [What do we know about the cardiovascular toxicity of the NSAIDs?] |
| Q56966981 | ¿Está incrementada la mortalidad cardiovascular en la artritis reumatoide? Posición en contra |
Search more.